Performance Evaluation of Lucie™ for Hydration of Dialysis Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

March 31, 2025

Conditions
Diabetes
Interventions
DEVICE

Diabetes Treatment

Lucie™ is an innovative medical device for measurement by bio-impedancemetry. It has been developed specifically to meet medical needs in nephrology. The aim of the study is to compare its performance with a reference device validated in nephrology nephrology, the Body Composition Monitor® (BCM) from Fresenius.

All Listed Sponsors
lead

Home Habilis

INDUSTRY